Rare diseases
Investigational molecules
Locations
Study on Extended Access to Momelotinib for Patients with Myelofibrosis
PolandStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
PolandStudy of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer
PolandStudy on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
PolandStudy of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)
PolandLong-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome
PolandStudy Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma
PolandStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
PolandStudy on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis
PolandStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
PolandStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
PolandStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
